Medidata Solutions and INC Research Reach One-Year ASPire to Win Milestone

Medidata Solutions, a global provider of electronic clinical data
capture (EDC), management and reporting solutions, and INC Research, a
therapeutically-focused contract research organization (CRO) with a
trusted process for delivering reliable results, today announced their
one-year ASPire to Win(TM) partnership milestone. In addition to INC
Research´s experience offering eClinical solutions to its customers,
keys to the success of this partnership include Medidata Rave´s fast
and easy deployment capabilities, robust reporting tools and ability
to handle any size global study.

Since November 2006, INC Research has implemented Medidata Rave(R)
in 23 studies for 14 sponsors, across Phases I - IV and in a range of
categories including CNS, pediatrics, oncology and infectious disease.
Medidata Rave has been deployed to manage trials of all sizes, from
three to 1,000 participants, and in global locations including Asia,
Europe and South America. The partnership has also yielded 15
Rave-certified study builders within INC Research´s clinical
programming and data management team in the U.S. and Europe. With
these certifications, INC Research can independently build and
maintain studies in Rave and easily deploy Rave at the site level.

Medidata Rave plays an integral role in INC Research´s Trusted
Process(TM), which is its four-phased approach to proactively lead
customers through their drug and device development programs with
repeatable and measurable methodology. Rave helps ensure predictably
dependable outcomes and actionable results by increasing efficiency,
decreasing time to trial completion and maintaining clean data in the
system at all times.

"With Rave as part of our Trusted Process, we are able to launch
Rave-enabled studies quickly and efficiently and provide our customers
with a modern, flexible and single system for EDC and CDMS," said
Alistair Macdonald, senior vice president of data services for INC
Research. "In addition to easy deployment, Medidata Rave can run very
complicated studies faster than any other system available today.
Moreover, sites are clearly very comfortable working with the Medidata
Rave platform, and data managers benefit from access to data in real
time with Rave´s built-in reporting tools, providing insight
throughout trials."

In addition to Rave, INC Research has also been impressed with
Medidata´s services and support teams.

"Medidata´s work ethic aligns with ours - through open
communication, rapid response to our questions, and focus on customer
care and management. We appreciate that Medidata continually strives
to deliver on time and exceed our expectations. We look forward to the
next phase of our relationship, which includes influencing product
development based on market trends," said Macdonald.

"INC Research is an industry leader in its approach to EDC, and
the clear investment in Rave knowledge transfer across its clinical
and data services organizations will help streamline clinical
processes for customers worldwide," said Tarek Sherif, CEO of Medidata
Solutions. "We look forward to continuing our relationship into 2008
and beyond."

About INC Research

INC Research is a therapeutically-focused contract research
organization with an unrivaled reputation for conducting global
clinical development programs of the highest integrity. Pharmaceutical
and biotechnology companies look to INC Research for a complete range
of customized Phase I through Phase IV programs in therapeutic areas
of specialty, and in innovative pediatric trials. The company´s
Trusted Process(TM) methodology and therapeutic foresight leads
customers to more confident, better-informed drug and device
development decisions. INC Research is headquartered in Raleigh, North
Carolina, and now in 24 locations in 32 countries worldwide. For more
information please visit http://www.incresearch.com/.

About Medidata Solutions Worldwide

Medidata Solutions helps the world´s leading pharmaceutical,
biotechnology, medical device and research organizations maximize the
value of their clinical research investments. Innovative process
design, technology and services streamline clinical trials by
providing early visibility to reliable clinical data - the lifeblood
of every research organization. Working with companies and
institutions both large and small, Medidata Solutions helps clinical
researchers safely accelerate the process of bringing life-enhancing
treatments to market - on six continents and in more than 80
countries. Medidata Solutions brings significant value to its broad
client base with deep clinical experience and expertise in more than
20 therapeutic areas, projects in Phase I, II, III, IV, registries and
surveillance, and studies with thousands of investigators and
tens-of-thousands of subjects. For more information, please visit
www.mdsol.com.